Precision Business Insights has published a report on the global clinical trial imaging market, estimating its value at USD 1.2 Billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/global-clinical-trial-imaging-market

Market Definition:

The use of medical imaging (such as MRI, CT, PET, ultrasound, etc.) in clinical trials to gauge the effects of a medication or treatment on the body is known as clinical trial imaging.

Drivers:

1) Use of imaging biomarkers.
2) Advanced imaging modalities.

The global clinical trial imaging market segmentation:

1) By Product & Services: Software and Services.
2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography and Other Modalities.
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes and Other End-Users.

Regional Overview:
The report also examines the current concerns and their Future Effects on the clinical trial imaging market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the clinical trial imaging market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like ICON plc | Parexel International | Medpace Holdings | Clario | IXICO plc | Radiant Sage LLC | Intrinsic Imaging LLC | BioTelemetry, Inc. | Biomedical Systems Corporation | Cardiovascular Imaging Technologies | WorldCare Clinical | Median Technologies | Navitas Life Sciences | Resonance Health Ltd. | Imaging Endpoints | Prism Clinical Imaging | Invicro LLC (Konica Minolta) | VirtualScopics Inc. | WCG Clinical | Synarc Imaging (now part of Clario) | AG Mednet | Medical Metrics, Inc. | Calyx (formerly Perceptive Informatics) | GE Healthcare Clinical Research Imaging | Siemens Healthineers Clinical Trials Imaging | Quibim

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747